Expression of an Activation Antigen, Mo3e, Associated With the Cellular Response to Migration Inhibitory Factor by HL‐60 Promyelocytes Undergoing Monocyte‐Macrophage Differentiation by Todd, Robert F. et al.
Journal of Leukocyte Biology 41:492-499 (1987)
© 1987 Alan R. Liss, Inc.
Expression of an Activation Antigen, Mo3e, Associated
With the Cellular Response to Migration Inhibitory Factor
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HL-60 promyelocytic cells acquire the surface expression of the Mo3e antigenic deter-
minant after exposure to PMA or compounds that raise intracellular concentrations of
cyclic AMP (dibutyryl cyclic AMP or a combination of cholera toxin and IBMX). The
expression of Mo3e by these stimulated HL-60 cells coincides with the development of
features of monocyte-macrophage differentiation (characteristic morphology, nonspe-
cific esterase activity, and respiratory burst activity). During in vitro monocyte-macro-
phage differentiation, HL-60 cells become responsive to migration inhibitory factor
(MIF); the MIF responsiveness of differentiated HL-60 cells is blocked by anti-Mo3e
monoclonal antibody. These findings further support the relationship between the
expression of Mo3e and the cellular response to MIF.
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INTRODUCTION
We have previously reported the identification of a
protease-sensitive plasma membrane antigen, Mo3e (p75,
50 by Western blot analysis) that is expressed by human
monocytes after exposure of these cells in vitro to acti-
vating stimuli that include bacterial lipopolysaccharide
(LPS), muramyl dipeptide, phorbol myristate acetate
(PMA), and other biologically active phorbol compounds
[13, 22]. Anti-Mo3e monoclonal antibody blocks the re-
sponse of human monocytes to migration inhibitory fac-
tor (MIF), indicating a functional association between the
expression of Mo3e and (MIF) responsiveness [13]. We
now report that pharmacological inducers of monocyte-
macrophage differentiation stimulate the expression of
Mo3e by the human promyelocytic cell line, HL-60.
Culture of HL-60 cells in medium containing PMA (10
nM), dibutyryl cyclic AMP (0.5 mM), or the combina-
tion of cholera toxin (10 ng/ml) and 3-isobutyl-l-meth-
ylxanthine (IBMX) ( 1 mM) provokes the acquired ex-
pression of Mo3e coincident with other features of mono-
cyte-macrophage differentiation (monocytic morphology,
nitroblue tetrazolium [NBTJ reduction, nonspecific ester-
ase [NSE] staining). The surface density of Mo3e (as
measured by indirect immunofluorescence) increases as
a function of culture duration (24-96 hr of incubation).
Exposure of HL-60 cells to 1 , 25-dihydroxycholecal-
ciferol (500 nM) for 72-96 hr stimulates a variable degree
of Mo3e expression, while cells cultured in medium
containing inducers of granulocytic differentiation (reti-
noic acid or DMSO) are Mo3e-negative. Previous studies
have shown that PMA-stimulated HL-60 cells acquire
responsiveness to MIF [ 14], and we now demonstrate
that MIF responsiveness of PMA-induced HL-60 cells is
inhibited by anti-Mo3e monoclonal antibody. These ob-
servations indicate that the expression of MIF response-
associated antigen Mo3e is an inducible plasma mem-
brane marker of monocytic cells derived from HL-60.
The metabolic events that may be responsible for expres-
sion of Mo3e by activated human monocytic cells are
discussed.
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MATERIALS AND METHODS
Media and Reagents
The following media and tissue culture additives were
purchased from GIBCO Laboratories (Grand Island,
NY): RPMI 1640 (320-1875), L-glutamine 200 mM (320-
5030), and penicillin-streptomycin solution (600-5070).
Fetal calf serum (FCS) was purchased from HyClone
Laboratories (Logan, UT). Lots of RPMI 1640 and FCS
were preselected for low endotoxin activity ( < 0. 1 ng/
ml). The following reagents were purchased from Sigma
Chemical Co. (St. Louis, MO): cholera toxin (C30l2);
N6, 2 ‘-O-dibutyryladenosine 3 ‘ :5 ‘-cyclic monophosphate
(DO627); 3-isobutyl- 1-methylxanthine (15879); dimethyl
sulfoxide (D5879); trans retinoic acid (R2625); 413-phor-
bol 12-myristate 13-acetate (P8139); nitroblue tetrazo-
hum (N6876): a-naphthyl acetate (nonspecific) esterase
kit (90-A 1 ) . 1 , 25-Dihydroxycholecalciferol (Ro2 1-5535)
and human recombinant interferon-rny were the gifts of
Dr. M.R. Uskokovic and S. Pestka (Hoffmann-La Roche,
Inc. Nutley, NJ), respectively. PMA was dissolved in
DMSO (1 mg/ml) and stored at -80#{176}C. Stock solutions
of 1 , 25-dihydroxycholecalciferol and trans retinoic acid
were prepared in 100% ethanol and stored at -80#{176}C.
Monoclonal Antibodies
The generation and characterization of monoclonal an-
tibodies anti-Mo! (1gM), anti-Mo2 (1gM), anti-Mo3e
(1gM), and anti-Pit 1 (1gM) have been described [22, 24,
26, 27]. Antibody containing ascites was used in all im-
munofluorescence assays.
HL-60 Cell Line
The human promyelocytic cell line HL-60 [2] was
obtained from Dr. Edward Prochownik (University of
Michigan) and grown in RPM! !640-FCS (RPMI 1640
medium supplemented with 10% FCS, L-glutamine 2
mM, penicillin 50 U/mI, and streptomycin 50 j.g/ml).
The cell line was maintained in log growth phase by
thrice-weekly feeding.
Culture of HL-60 With Various Differentiating
Reagents
In experiments designed to assess the effect of various
differentiating agents on HL-60 Mo3e expression, cells
were cultured (3-4 x !05/ml) in 60- or 100-mm plastic
culture dishes (Falcon Plastic, Oxnard, CA) containing
fresh 1640-FCS to which various chemical agents were
added ( to a total volume of 6 or 10 ml, respectively).
The final concentrations of DMSO or ethanol, which was
used as an initial diluent for certain reagents as indicated
earlier, did not exceed 0.4%, and cultures containing
appropriate quantities of DMSO or ethanol were run in
parallel to control for any minor diluent effects. Cultures
were incubated at 37#{176}Cin a humidified atmosphere of
5% CO2 in air for 24 to 96 hr. At the end of culture,
medium containing nonadherent cells was removed and
combined with adherent cells harvested by exposure to
0.5 mM EDTA followed by scraping. These recovered
nonadherent and adherent cells were washed, counted
(viability assessed by trypan blue exclusion), and resus-
pended in phosphate-buffered saline supplemented with
glucose 1 mg/ml and 2.5% human pooled AB serum) at
a concentration of 5 to 20 x 106 cells per ml for subse-
quent immunofluorescence staining.
lmmunofluorescence Flow Cytometric Analysis
Aliquots containing 0.5 to 2.0 x 106 cells were sub-
jected to indirect immunofluorescence staining for the
expression of Mo3e or Mo2 relative to background stain-
ing using an 1gM-negative control reagent (anti-Pit I) as
described [22] . Intact (live) cells were selected by gating
(log forward angle versus log right angle light scatter).
Immunofluorescence intensity as a measure of relative
antigen expression was analyzed on a Coulter Electronics
(Hialeah, FL) EPICS C flow cytometer with the use of a
logarithmic amplifier. The channel number (log scale)
representing the mean fluorescence intensity (major flu-
orescence peak) of 5,000 cells exposed to either experi-
mental or isotype-identical negative control antibodies
was determined. The corresponding linear fluorescence
intensity channel was calculated from a logarithmic-lin-
ear calibration formula [ 17]. Specific fluorescence inten-
sity represents the computed mean channel number (0 to
296 channels, linear scale) of cells stained with the ex-
perimental monoclonal antibody minus the mean channel
of cells stained with the negative control reagent [22].
Assessment of Morphological, Histochemical, and
Metabolic Changes Associated With HL-60
Differentiation
In parallel to immunofluorescence analysis of Mo3e
antigen expression, HL-60 cells cultured in the presence
of differentiating stimuli were assessed for changes in
cellular morphology, the acquisition of nonspecific ester-
ase activity [30], and the capacity to reduce NBT. The
morphological appearance of cells was assessed by light
microscopic examination of Wright-Giemsa-stained cy-
tocentrifuge smears; nonspecific esterase activity was
determined according to the Sigma kit protocol (#90-
A 1). The ability to reduce NBT was assayed by incubat-
ing 5 X l05cells in 1 ml PBS containing 0.5 mg NBT and
1 g PMA ( 1 jd of a 1 mg/mI stock solution in DMSO)
for 20 mm at 37#{176}C.Cytocentrifuge smears were then
prepared, and the number of cells containing blue-black
deposits was counted [211. A minimum of 200 cells were
examined per determination.
MIF Assay
The response of PMA-stimulated or control HL-60
cells to MIF was expressed as the percentage of migra-
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tion inhibition according to the following formula [131:
% inhibition of migration = 1 - (average migration of
cells exposed to MIF/average migration of cells exposed
to control medium) x 100% . Migration of HL-60 cells in
the presence or absence of MIF-containing supernatants
was assessed in a microcapillary assay as previously
described [ 14] . The effect of anti-Mo3e monoclonal an-
tibody on the response of HL-60 cells to MIF was deter-
mined by performing the microcapillary assay in the
presence of medium containing a saturating concentration
of anti-Mo3e ascites fluid as previously reported [13].
One-Dimensional Electrophoresis and Western
Immunoblotting
One-dimensional polyacrylamide gel electrophoresis in
the presence of sodium dodecyl sulfate (SDS-PAGE) was
performed according to the procedure of Laemmli [12].
HL-60 cells were cultured for 16-24 hr in 1640-FCS in
the absence or presence of either 100 nM PMA or 0.5
mM dibutyryl cyclic AMP. The cells were harvested,
washed twice, and solubilized in lysis buffer (10 mM
tris-HC1 buffer, pH 7.4, 0.5% Nonidet P40, 150 mM
NaCl, 10 mM leupeptin, 3 mM iodoacetamide, 1 mM
phenylmethylsulfonylfluoride) at 4#{176}Cfor 30 mm before
electrophoresis. Proteins were electrophoretically trans-
ferred onto nitrocellulose sheets by the Western blotting
technique [28] and then probed with anti-Mo3e antibody
and the horseradish peroxidase Vectastain kit (Vector
Laboratories, Burlingame, CA). The MW. reference
proteins used for SDS-PAGE were phosphorylase-b, bo-
vine serum albumin, ovalbumin, and carbonic anhydrase.
RESULTS
Expression of Mo3e by HL-60 Cells Cultured in
Medium Containing Certain Inducers of Monocytic
Differentiation
We have previously reported that HL-60 cells cultured
in medium containing 413-phorbol 12-myristate 13-acetate
(PMA) under conditions that induce monocyte-macro-
phage differentiation acquire the surface expression of
Mo3e [23]. Experiments were performed to determine if
other inducers of HL-60 differentiation would stimulate
the expression of surface Mo3e. As recently reported by
Chaplinski and Niedel [4,5], culture of HL-60 cells in
medium containing agents that stimulate the production
of intracellular cyclic adenosine monophosphate (cyclic
AMP) results in differentiation along the monocyte-mac-
rophage pathway. Exposure of HL-60 cells to dibutyryl
cyclic AMP (0.5 mM), cholera toxin (10 ng/ml), 3-
isobutyl-l-methylxanthine (IBMX, 1 mM), or combina-
tions of these agents (eg., cholera toxin plus IBMX) for
24-96 hr resulted in the acquired expression of Mo3e
(Fig. 1 and Table 1) that coincided with the development
of features of monocyte-macrophage differentiation: co-
expression of the monocyte surface marker, Mo2 (gp 55)
(Fig. 2), monocyte-macrophage morphology, cr-naphthyl
acetate (nonspecific) esterase, and the capacity to reduce
nitroblue tetrazolium (Fig. 3). While dibutyryl cyclic
AMP was sufficient to induce Mo3e expression in excess
of that stimulated by PMA, cholera toxin (an activator of
adenylate cyclase) and IBMX (a cyclic AMP phosphodi-
esterase inhibitor) were synergistic in stimulating com-
parable levels of surface Mo3e expression (Table 1).
Other pharmacological inducers of cyclic AMP produc-
tion such as isoproterenol or prostaglandin E2 were less
active in stimulating Mo3e expression (not shown). Ex-
posure of HL-60 cells to human recombinant gamma
interferon (10-1,000 U/mI) for 1-4 days failed to induce
detectable levels of surface Mo3e expression (not shown).
Culture of HL-60 cells in medium containing 1,25-dihy-
droxycholecalciferol (500 nM) for 1-4 days induced
prominent features of monocyte-macrophage differentia-
tion, but the degree of surface Mo3e expression by these
cells was variable (one subline of HL-60 was, as previ-
ously reported [23], consistently negative for Mo3e
expression despite other features of monocyte-macro-
phage differentiation). HL-60 cells exposed to inducers
of granulocytic differentiation such as trans retinoic acid
(1 j.M) or DMSO (1.2%) failed to stimulate surface
Mo3e expression (not shown).
Identification of Mo3e in Lysates of HL-60 Cells by
Western Blotting
Western blot analysis of lysates from control and PMA-
stimulated HL-60 cells probed with anti-Mo3e monoclo-
nal antibody demonstrated two polypeptides of 75 and 50
kD. Consistent with previous observations in control and
PMA-stimulated monocytes [13 , 25], the 75 kD polypep-
tide was detectable in lysates from both unstimulated and
PMA-cultured HL-60 cells, while the 50 kD band was
consistently seen only in the lysates of PMA-stimulated
cells (Fig. 4). Similar results were observed after stimu-
lation of HL-60 cells with dibutyryl cyclic AMP (not
shown).
Inhibition of MIF Response of PMA-Stimulated HL-
60 Cells by Anti-Mo3e Monoclonal Antibody
As previously reported [13], anti-Mo3e monoclonal
antibody blocks the response of human peripheral blood
monocytes to MIF indicating that the expression of Mo3e
is functionally associated with the response to MIF. Con-
sistent with this notion is the fact that Mo3e-negative
unstimulated HL-60 cells are unresponsive to MIF, but
acquire responsiveness to MIF after exposure to PMA
[14] under conditions that stimulate Mo3e expression. As
shown in Table 2, the MIF response of PMA-cultured
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Fig. 1 . Stimulation of surface Mo3e expression by HL-60 cells after culture in me-
dium containing PMA or agents that increase intracellular cyclic AMP. HL-60 cells
(3 x 105/mI) were cultured for 24 or 48 hr in medium containing the indicated stimuli
(same concentrations as in Table 1). After culture, the cells were stained by indirect
immunofluorescence for the expression of Mo3e (cross-hatched histograms) versus
control 1gM antibody binding (open histograms).
DISCUSSION
Mo3e is a protease-sensitive antigenic determinant that
is selectively expressed by human peripheral blood
monocytes and U-937 monoblasts after exposure of these
cells in vitro to several activating stimuli [13,22]. Since
unactivated monocytic cells express little or no surface
Mo3e that is detectable by indirect immunofluorescence,
the acquisition of Mo3e represents an immunological
marker of phagocyte activation [221. The physiological
significance of Mo3e expression is suggested by the re-
suits of antibody-blocking experiments in which the
monocyte response to MIF is inhibited by incubation of
monocytes in medium containing anti-Mo3e monoclonal
antibody (other 1gM anti-monocyte reagents having no
inhibitory effect) [ 13] . Whether Mo3e represents an epi-




Exp. 1h Exp 2b Exp. 3b
24 hr 48 hr 48 hr 72 hr 96 hr 48 hr 72 hr
- 0.l2c 0.04 0.34 0.05 0.03 0.10 0.03



































































































HLJ cells (3 x l05/ml) were cultured for the indicated times in medium containing dibutyryl cyclic AMP (dbCAMP, 0.5 mM), 3-isobutyl-
1-methylxanthine (IBMX, 1 mM), cholera toxin (CT, 10 ng/ml), phorbol myristate acetate (10 nM), dimethylsulfoxide diluent (DMSO,
0.00062% vlv), or no additives (-). After culture, the cells were stained by indirect immunofluorescence for the expression of Mo3e.
bPMT setting in experiments 1 and 2 was 1100; in experiment 3, 1150 mV.
cNumbers indicate the specific fluorescence intensity.
dNumbers in parentheses indicate the fluorescence intensity of cells (computed mean linear channel numbers) stained with negative control
antibody (this represents the background immunofluorescence that was subtracted from the experimental immunofluorescence values to yield
the specific fluorescence intensity).
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tope within the MIF ligand binding domain of the MIF
receptor or an epitope of a molecule with an accessory
role in the response to MIF remains to be determined. In
this report, we extend our previous observations relating
to the induction of Mo3e expression and its relationship
to MIF responsiveness by an examination of HL-60 pro-
myelocytic cells during pharmacologically induced mye-
bid differentiation.
In 1979, Rovera and coworkers reported that exposure
of HL-60 cells to PMA induced their transformation into
cells that exhibited many features of monocyte-macro-
phage differentiation [20] . Other investigators found that
several additional agents could induce HL-60 monocyte-
macrophage differentiation: other biologically active
phorbol compounds [29], diacylglycerol compounds [7],
lectin-stimulated lymphokine supernatants [8], human
gamma interferon [6, 11], 1 , 25-dihydroxycholecalciferol
[15 , 16], and compounds that stimulate the generation of
intracellular cyclic AMP [4,5]. Conversely, differentia-
tion of HL-60 cells along the granulocytic pathway could
be stimulated by exposure to DMSO [3] or to retinoic
acid [1]. Thus, the transformation of HL-60 cells by
selective inducers of monocytic or granulocytic matura-
tion serves as an in vitro model of human myeloid differ-
entiation. Accompanying the changes in cellular
morphology, histochemistry, and function that occur dur-
ing HL-60 differentiation, are changes in surface antigen
expression that reflect differentiation at the plasma mem-
brane level [9, 10, 19, 24]. These observations led us to
examine HL-60 cells for the acquired expression of the
MIF-associated determinant Mo3e. Unstimulated HL-60
cells are negative for the surface expression of Mo3e as
measured here by indirect immunofluorescence. How-
ever, exposure of HL-60 to PMA or to agents that raise
the intracellular concentration of cyclic AMP stimulates
surface Mo3e expression under conditions resulting in
features of monocytic differentiation (as assessed by
characteristic morphology, histochemistry, and the acqui-
sition of respiratory burst activity). Either cell-permeant
dibutyryl cyclic AMP or the combination of cholera toxin
(an activator of adenylate cyclase) and IBMX (an inhibi-
tor of cyclic AMP phosphodiesterase) induce the expres-
sion of Mo3e to a surface density that (on a per cell basis)
exceeds that provoked by optimally stimulatory concen-
trations of PMA. Surface Mo3e expression becomes ev-
ident within 24 hr of exposure to these agents (preceding
other features of monocytic differentiation) and generally
increases as a function of time. Exposure of HL-60 cells
to recombinant gamma interferon had no positive effect
in inducing Mo3e expression, while culture of cells in
medium containing 1, 25-dihydroxycholecalciferol pro-
duced variable degrees of Mo3e expression. Retinoic
Mo3e Mo2
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Fig. 2. Comparison between the expression of Mo3e and the monocyte marker Mo2
(gp 55) by HL-60 cells stimulated by agents that increase intracellular cyclic AMP and
by PMA. HL-60 cells (3 x 105/ml) were cultured for 72 hr in medium containing the
indicated stimuli (same concentrations as in Table 1). After culture the cells were
stained by indirect immunofluorescence for the expression of Mo3e (cross-hatched
histograms under the Mo3e column), Mo2 (cross-hatched histograms under the Mo2
column), versus control gM antibody binding (open histograms).








acid and DMSO, inducers of granulocytic differentiation,
failed to stimulate Mo3e expression.
In a previous report [23], we suggested that the induc-
tion of Mo3e expression by monocytic cells is a cellular
response to activation of protein kinase C and calcium
mobilization, metabolic consequences of receptor-medi-
ated phosphatidylinositol degradation with the generation
of 1, 2-diacylglycerol (the endogenous activator of pro-
tein kinase C) and inositol trisphosphate (a promoter of
calcium release from intracellular stores) [see 18 for
review] . This notion was based on the stimulatory effect
of agents that mimic the effect of endogenous 1 , 2-diacyl-
glycerol (PMA and other biologically active phorbol
compounds, mezerein, and synthetic cell-permeant dia-
cylglycerols) either alone or in concert with calcium
ionophore, ionomycin, in inducing surface Mo3e expres-
sion [23]. Consistent with this idea was the inhibitory
effect of various inhibitors of protein kinase C activation
or calcium mobilization on Mo3e expression stimulated
by PMA [23]. As suggested by this report, the surface
expression of Mo3e may also be a consequence of the
generation of increased concentrations of intracellular
cyclic AMP either as a result of the incorporation of
exogenous cell-permeable cyclic AMP (dibutyryl cyclic
AMP) or stimulation by the adenylate cyclase agonist,
cholera toxin, in synergy with an inhibitor of cyclic AMP
degradation (IBMX). Consistent with this idea are the
results of experiments in which culture of peripheral
blood monocytes for 24 hr in medium containing cholera
toxin, dibutyryl cyclic AMP, or IBMX stimulated Mo3e
expression to a surface density that approaches that stim-
ulated by LPS (Todd, R.F. , unpublished). It would thus
appear that either the phosphatidylinositol or adenylate
cyclase signal transduction pathways may promote cel-
lular effector responses that include surface Mo3e ex-
pression.
The structural features of Mo3e seen in unstimulated
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Fig. 3. Comparison between surface Mo3e expression and
features of monocyte-macrophage differentiation. HL-60 cells
(2.5 x 105/ml) were cultured for 72 hr in medium containing the
indicated stimuli (same concentrations as in Table 1). After
culture the cells were stained by indirect immunofluorescence
for the expression of Mo3e (as measured by specific fluores-
cence intensity [SF1]); separate aliquots were assayed for re-
duction of nitroblue tetrazolium (NBT), cr-naphthyl acetate
(nonspecific) esterase activity (NSE), and morphological char-
acteristics after Wright-Giemsa staining of cytocentrifuge
smears, and scored as the percentage positive of the 200 cells
counted. Characteristics of “differentiated” cells included an
increase in the amount of cytoplasm with the appearance of a
ruffled, irregular shape and a loss of azurophilic cytoplasmic
granules (characteristic of promyelocytes).
are similar to those observed in human monocytes
[13 , 25]. A 75 kD polypeptide is detectable in lysates of
either unstimulated or PMA-activated cells (with no ob-
vious quantitative change after activation). In the iysates
of activated cells, a second polypeptide of 50 kD is
consistently seen. While the relationship between p75
and p50 is not as yet clear, p50 may represent the deter-
minant that is detectable by surface antibody binding to
intact cells (an idea that is consistent with the results of
preliminary immunoprecipitation experiments [Todd, un-
published]).
A relationship between surface Mo3e expression and
MIF responsiveness is further supported by the parallel
acquisition of Mo3e expression and MIF responsiveness
by PMA-stimulated HL-60 cells. Mo3e-negative, un-
stimulated HL-60 cells are unresponsive to MIF, but after
24-hr exposure to PMA under conditions that promote
the surface expression of Mo3e, HL-60 cells acquire
responsiveness to MIF [14] that can be blocked by anti-
Mo3e monoclonal antibody. While these results are con-
sistent with the idea that Mo3e represents the surface
receptor for MIF, the effect of anti-Mo3e antibody on the
binding of radiolabeled purified MIF lymphokine (cur-
rently unavailable) must be determined to directly test
this hypothesis.
TABLE 2. Response of PMA-Stimulated HL-60 Cells to




Exp. HL-60 HL60/PMAuI HL-60/PMA
No. + antiMo3et)
0 42 ND
2 1 43 15 (65)c
3 0 48 0(100)
4 0 43 0(100)
5 0 35 4(89)
6 0 40 0(100)
“HL-60 cells (5 x l05/ml) were cultured for 16-20 hr in medium
containing PMA 100 nM.
hMIF assay performed in medium containing anti-Mo3e monoclonal
antibody (1/250 dilution of ascites). An irrelevant negative control
1gM monoclonal antibody (anti-Mol) had no inhibitory effect.
cNumbers in parentheses are percentage inhibition of the MIF
response.
AB CD
Fig. 4. Western blot analysis of HL-60 NP-40 cellular lysates.
Lane A represents the Western blot of unstimulated HL-60 cells.
Lane B represents the Western blot of HL-60 cells cultured for
22 hr in medium containing PMA 100 nM. Both lanes were
probed with anti-Mo3e monoclonal antibody and then rabbit
anti-mouse 1gM (biotin conjugate) and with avidin, and finally
with biotin-horseradish peroxidase. Lysates from unstimulated
and PMA-stimulated HL-60 cells initially probed with a negative
control gM monoclonal antibody (anti-Mol) were negative
(lanes C and D, respectively). The molecular weight markers
are shown on the left.
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